Steve Jobs’ precipitous weight loss has Wall Street concerned that the God-like leader’s health is deteriorating–especially in light of Jobs’ decision not to disclose his pancreatic cancer a few years ago. It’s time for Apple to address these concerns forthrightly and detail a succession plan.
Silicon Alley Insider: Concerns about Steve Jobs’ health aren’t going away. Today’s NY Post quotes a “Wall Street source” who says hedge fund managers are still freaked out after seeing Jobs’ rail-thin appearance at the iPhone launch event last month. It also cites “multiple sources” who’ve met Steve in recent weeks and are “troubled by his thin appearance.” Reuters has now picked up the Post’s story; the wire service doesn’t add anything to the report, but the fact that it is repeating it gives it extra weight.
We’ve now heard a couple of explanations for Steve’s gaunt frame at the WWDC conference: Some reports suggest that it’s a side effect of a treatment for the pancreatic cancer he suffered in 2003. Apple itself said that Steve was sick prior to WWDC, and was on antibiotics at the time of his presentation.
We’ll take Apple at its word: Steve is OK. But his appearance, coupled with the fact that he previously didn’t disclose his cancer for 9 months, mean that he’s going to be dogged by these questions indefinitely. Apple could try quashing the issue by issuing a comprehensive health report — in the same way that presidential candidates do — but we think Steve is unlikely to accept that level of public scrutiny.
NOW WATCH: Briefing videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.